All lobbying filings
CHATTEM, INC D/B/A OPELLA
Lobbying for CHATTEM, INC D/B/A OPELLA · Healthcare related to nonprescription drugs and dietary supplements.
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Expenses
$180,000.00
What this organization spent lobbying with its own staff.
Reported using A: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
New Jersey
Government bodies contacted
2
Lobbying activity
2
Regulatory pathways for OTC drugs and dietary supplements, including OMUFA and Rx to OTC switch.
Retail and cargo theft of medicines, counterfeit and diverted medicines.